Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer. Nakahama K, Izumi M, Yoshimoto N, Fukui M, et al. Cancer Chemother Pharmacol 2023 Aug 22. doi: 10.1007/s00280-023-04573.

Read + Share

Amedeo Smart

Independent Medical Education

Nakahama K, Izumi M, Yoshimoto N, Fukui M, et al. Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer. Cancer Chemother Pharmacol 2023 Aug 22. doi: 10.1007/s00280-023-04573.
PMID: 37606723